Felstein M V, Mowat A M
Department of Bacteriology and Immunology, University of Glasgow, Western Infirmary, Scotland, U.K.
Adv Exp Med Biol. 1987;216A:653-60. doi: 10.1007/978-1-4684-5344-7_77.
We have used the intestinal phase of a GvHR to investigate the immunological basis of enteropathies associated with CMI. The nature of the damage depends on the model of GvHR used. Adult unirradiated (CBAxBALB/cF1) mice with GvHR developed an entirely proliferative enteropathy characterized by crypt hyperplasia, increased numbers of IEL and enhanced NK cell activity, but there was no villus atrophy or CTL. Although neonatal or irradiated adult (CBAxBALB/c)F1 mice with GvHR developed a destructive enteropathy with marked villus atrophy and CTL activity, this also required an early proliferative phase identical to that found in unirradiated adult mice. Thus, we propose that proliferative enteropathy in GvHR is due to soluble mediators released by a local DTH reaction but that villus atrophy also requires activation of a further population of effector cells, which may be CTL or suppressor T cells.
我们利用移植物抗宿主反应(GvHR)的肠道阶段来研究与细胞介导免疫(CMI)相关的肠病的免疫基础。损伤的性质取决于所使用的GvHR模型。患有GvHR的成年未受照射(CBA×BALB/cF1)小鼠会出现一种完全增殖性肠病,其特征为隐窝增生、肠上皮内淋巴细胞(IEL)数量增加以及自然杀伤(NK)细胞活性增强,但没有绒毛萎缩或细胞毒性T淋巴细胞(CTL)。尽管患有GvHR的新生或受照射成年(CBA×BALB/c)F1小鼠会出现具有明显绒毛萎缩和CTL活性的破坏性肠病,但这也需要一个与未受照射成年小鼠中发现的早期增殖阶段相同的阶段。因此,我们提出,GvHR中的增殖性肠病是由于局部迟发型超敏反应(DTH)释放的可溶性介质所致,但绒毛萎缩还需要激活另一群效应细胞,这些细胞可能是CTL或抑制性T细胞。